Analgesic and anti-inflammatory/antirheumatic reporting in Türkiye: Appraisal of the 2014-2020 UZEM compendium with descriptive analyses for 2018-2020
Year: 2026
Type: article
Abstract: Aims Published poison-center tables may use different counting units, denominators, and medication definitions, limiting their reuse. We appraised the availability and comparability of National Poison Center (UZEM) medication-group data and described analgesic and separately classified anti-inflammatory/antirheumatic records. Methods This retrospective reporting appraisal and descriptive secondary analysis used the 728-page public 2014-2020 UZEM compendium. Eligible tables contained target-group records, related agents, age strata, or required denominators. Seven study-specific domains guided comparison decisions: temporal availability, denominators, agent definitions, repeated reporting, numerical consistency, clinical linkage, and coding changes. Primary descriptive measures were annual group counts and all-case percentages for 2018-2020, calculated using explicit same-year denominators. Published entries and arithmetic were verified against source tables. Repeated table entries were excluded from summation; incompatible agent definitions remained separate. No hypothesis testing was performed. Results Twenty-four core tables were included; five repeated full-distribution counts in top lists. Individual ages and target-group sex distributions were unavailable. For 2018, 2019, and 2020, analgesic counts were 13,423 (6.18%), 13,744 (6.31%), and 10,619 (5.66%); anti-inflammatory/antirheumatic counts were 20,560 (9.46%), 23,755 (10.90%), and 18,395 (9.81%). All-case denominators were 217,323, 217,936, and 187,528, respectively. Although analgesic counts decreased by 22.74% between 2019 and 2020, their share of human-health-product records changed from 8.96% to 8.63% (denominators 153,427 and 122,995, respectively). All 96 selected label/count/percentage combinations matched the source; 84 percentages with explicit denominators and five distributions comprising 1,242 rows were verified. General target-group distributions for 2014-2017 and group-linked clinical outcomes were not identified. Agent definitions differed across years, and coding stability was undocumented. Conclusions The appraisal linked annual medication-group summaries to their source definitions and documented denominator, classification, and clinical-linkage constraints on secondary use of the published compendium.
Source: Gulhane Medical Journal
Author: Yıldırım Cesaretli
Institution: Sağlık Bilimleri Üniversitesi
Language: English
Subfield: Emergency Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Funder: Hacettepe Üniversitesi
OpenAlex ID: W7236416325
